Icatibant
ATC B06AC02 · 9 markets · 59 records
GB 11 records · 1 strengths
- 30 mg/3 mLinjectionFirazyr 30mg/3ml solution for injection pre-filled syringes__no_trade__
AU 10 records · 3 strengths
- 30 mg/3 mLinjectionCipla IcatibantFyzant、Icatibant Lupin
- 10 mg/mLinjectionFIRAZYR icatibant (as acetate) 30 mg/3 mL injection pre-filled syringe
Records without a stated strength · 1 Cipla Icatibant、Firazyr、Fyzant、Icatibant Lupin、ICATIBANT WKT、ICATIBANT WOCKHARDT
US 9 records · 2 strengths
- 30 mg/3 mLinjectionFirazyrSAJAZIR、__no_trade__
- 10 mginjectionNo trade name
CN 5 records · 1 strengths
- 30 mg/3 mLinjectionManufacturer: TakedaPharmaceuticalsIntern… ×2__mah__:成都圣诺生物制药有限公司、__mah__:江苏豪森药业集团有限公司
ES 4 records · 2 strengths
- 30 mg/3 mLinjectionICATIBANTO GLENMARK PRECARGADAICATIBANTO STADA PRECARGADA
- 30 mginjectionFIRAZYR PRECARGADAICATIBANTO CIPLA PRECARGADA
CA 3 records · 1 strengths
- 10 mgliquidFirazyrIcatibant、MINT-ICATIBANT
TW 2 records · 2 strengths
- 30 mginjectionFirazyr 30 mg solution for injection in pre-filled syringe凡得適注射劑30毫克
Records without a stated strength · 1 Icanticure Injection、益康倍注射劑
EU 2 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 Firazyr、Icatibant Accord
HK 1 records · 1 strengths
Records without a stated strength · 1 Firazyr 30 mg solution for injection in pre-filled syringe
| Strength / form / release | US | GB | CA | AU | CN | ES | TW | HK | EU |
|---|---|---|---|---|---|---|---|---|---|
| 30 mg/3 mL injection | No trade name Firazyr SAJAZIR | No trade name Firazyr 30mg/3ml solution for injection pre-filled syringes | Cipla Icatibant Fyzant Icatibant Lupin | Manufacturer: TakedaPharmaceuticalsIntern… ×2 Manufacturer: 成都圣诺生物制药有限公司 Manufacturer: 江苏豪森药业集团有限公司 ×2 | ICATIBANTO GLENMARK PRECARGADA ICATIBANTO STADA PRECARGADA | ||||
| 30 mg injection | FIRAZYR PRECARGADA ICATIBANTO CIPLA PRECARGADA | Firazyr 30 mg solution for injection in pre-filled syringe 凡得適注射劑30毫克 | |||||||
| 10 mg liquid | Firazyr Icatibant MINT-ICATIBANT | ||||||||
| 10 mg injection | No trade name | ||||||||
| 10 mg/mL injection | FIRAZYR icatibant (as acetate) 30 mg/3 mL injection pre-filled syringe | ||||||||
unknown | Cipla Icatibant Firazyr Fyzant+3Icatibant Lupin ICATIBANT WKT ICATIBANT WOCKHARDT | Firazyr 30 mg solution for injection in pre-filled syringe | Firazyr Icatibant Accord | ||||||
injection | Icanticure 益康倍注射劑 |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
2 more strength/form rows are recorded only in CA · TW and are not shown in this table. Hay 2 filas de concentración/forma registradas solo en CA · TW que no se muestran en esta tabla. 另有 2 个规格/剂型仅在 CA · TW 有记录(未在本表显示)。 另有 2 個規格/劑型僅在 CA · TW 有記錄(未在本表顯示)。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.